Harmony Biosciences (HRMY)
Commercializes WAKIX for narcolepsy while developing next-generation pitolisant and rare-neurology therapies.
$40.71
vs last close−0.83 (−1.99%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 41 days
EPS estimate
$1.11
Revenue estimate
$274.5M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.85$0.78$0.68$0.87$0.38$0.55$1.28Pending
Estimate$0.74$0.59$0.78$0.92$0.84$0.76$0.96$1.11
Surprise+14.9%+32.2%−12.8%−5.4%−54.8%−27.6%+33.9%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$201.3M$184.7M$200.5M$239.5M$243.8M$215.4M$261.3MPending
Estimate$183.2M$206.1M$220.2M$240.0M$240.3M$220.8M$250.8M$274.5M
Surprise+9.9%−10.3%−8.9%−0.2%+1.4%−2.5%+4.2%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $1.19 | — | — |
| Sep 2027 | $1.07 | — | — |
| Jun 2027 | $1.02 | — | — |
| Mar 2027 | $0.83 | — | — |
| Dec 2026 | $1.05 | — | — |
| Nov 2026 | $1.11 | — | — |
| Aug 2026 | $0.96 | $1.28 | +33.9% |
| May 2026 | $0.76 | $0.55 | −27.6% |
| Feb 2026 | $0.84 | $0.38 | −54.8% |
| Nov 2025 | $0.92 | $0.87 | −5.4% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Jun 2020 | |||
| Aug 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $1.19 | — | — | $336.5M | — | — | — |
| Sep 2027 | $1.07 | — | — | $314.0M | — | — | — |
| Jun 2027 | $1.02 | — | — | $294.3M | — | — | — |
| Mar 2027 | $0.83 | — | — | $256.7M | — | — | — |
| Dec 2026 | $1.05 | — | — | $282.7M | — | — | — |
| Nov 3, 2026 | $1.11 | — | — | $274.5M | — | — | — |
| Aug 4, 2026 | $0.96 | $1.28 | +33.9% | $250.8M | $261.3M | +4.2% | +8.9% |
| May 7, 2026 | $0.76 | $0.55 | −27.6% | $220.8M | $215.4M | −2.5% | −4.2% |
| Feb 24, 2026 | $0.84 | $0.38 | −54.8% | $240.3M | $243.8M | +1.4% | +4.9% |
| Nov 4, 2025 | $0.92 | $0.87 | −5.4% | $240.0M | $239.5M | −0.2% | +4.7% |
| Aug 5, 2025 | |||||||
| May 6, 2025 | |||||||
| Feb 25, 2025 | |||||||
| Oct 29, 2024 | |||||||
| Aug 6, 2024 | |||||||
| Apr 30, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Oct 31, 2023 | |||||||
| Aug 1, 2023 | |||||||
| May 2, 2023 | |||||||
| Feb 21, 2023 | |||||||
| Nov 1, 2022 | |||||||
| Aug 2, 2022 | |||||||
| May 3, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 11, 2021 | |||||||
| Mar 25, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Aug 20, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |